MBX Biosciences, Inc.
MBX
$29.74
-$0.06-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.45% | -45.88% | -63.18% | -88.61% | -90.16% |
| Total Depreciation and Amortization | 1.64% | 8.37% | 41.15% | 62.50% | 55.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.63% | 13.96% | -17.85% | -24.19% | 106.36% |
| Change in Net Operating Assets | -65.74% | -126.18% | 163.64% | 1,002.08% | 725.44% |
| Cash from Operations | -46.21% | -56.03% | -65.25% | -80.31% | -71.00% |
| Capital Expenditure | -120.71% | -46.71% | -10.47% | -65.62% | -577.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.80% | 83.65% | -251.95% | -1,361.40% | -418.61% |
| Cash from Investing | 47.88% | 82.75% | -247.11% | -1,320.80% | -419.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.81% | 8.49% | 63,913.09% | 20,244.59% | 23,573.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -7.31% | -7.31% | -7.31% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.24% | 85.53% | -36.65% | -11,941.67% | -14,370.00% |
| Cash from Financing | -19.01% | -19.31% | 254.08% | 237.40% | 238.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.76% | 44.97% | 271.16% | -127.33% | 198.24% |